---
title: "301267.SZ (301267.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301267.SZ/news.md"
symbol: "301267.SZ"
name: "301267.SZ"
parent: "https://longbridge.com/en/quote/301267.SZ.md"
datetime: "2026-03-14T07:54:51.771Z"
locales:
  - [en](https://longbridge.com/en/quote/301267.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301267.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301267.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301267.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301267.SZ/news.md)


# 301267.SZ (301267.SZ) — Related News

### [To build a high-end ophthalmic equipment platform, Vision Micro Imaging has completed over 300 million yuan in Series C financing](https://longbridge.com/en/news/277414692.md)
*2026-03-02T06:38:16.000Z*
> Shivision Technology Co., Ltd. announced the completion of over 300 million RMB in Series C financing, led by China Life

### [Certain A Shares of Huaxia Eye Hospital Group Co.,Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2025.](https://longbridge.com/en/news/264751485.md)
*2025-11-07T00:25:32.000Z*
> Certain A Shares of Huaxia Eye Hospital Group Co., Ltd. are under a Lock-Up Agreement until 7-NOV-2025, lasting 1109 day

### [November 7th A-share lock-up release details: 18 companies released 10.195 billion in market value of restricted shares, with Huaxia Eye leading the way with 6.255 billion in released market value](https://longbridge.com/en/news/264745164.md)
*2025-11-06T23:51:01.000Z*
> On November 7th, 18 companies had their restricted shares unlocked, with a total unlocking volume of 714 million shares 

### [30 stocks will face lifting of restrictions next week](https://longbridge.com/en/news/263759112.md)
*2025-10-31T13:16:39.000Z*
> Next week, 30 stocks will be unlocked, with a total unlocked market value of 20.322 billion yuan. Huaxia Eye will unlock

### [The import monopoly of ophthalmic femtosecond lasers has escalated again; when will domestic products be on the table?](https://longbridge.com/en/news/257707304.md)
*2025-09-17T10:39:58.000Z*
> The ophthalmic femtosecond laser equipment market is experiencing an upgrade in import monopoly, with domestic products 

### [Crossing the Low Valley, These Ophthalmology Companies Are Making Landfall](https://longbridge.com/en/news/255756116.md)
*2025-09-03T09:40:54.000Z*
> Aier Eye Hospital, Huaxia Eye, Bright Eye Hospital Group, and HESH performed steadily in the first half of 2025, with re

### [Huaxia Eye's revenue and profit returned to growth in the first half of the year, with technological innovation and service upgrades forging the Huaxia brand](https://longbridge.com/en/news/254475650.md)
*2025-08-25T14:54:22.000Z*
> On the afternoon of August 24th, Huaxia Eye (301267) disclosed its semi-annual report. In the first half of 2025, the co

### [Huaxia Eye: Net profit attributable to the parent company in the first half of the year was 282 million yuan, a year-on-year increase of 6.20%](https://longbridge.com/en/news/254298891.md)
*2025-08-24T07:39:31.000Z*
> Huaxia Eye disclosed its semi-annual report on August 24, showing that the company achieved operating revenue of 2.139 b

### [Huaxia Eye: Has begun overseas expansion and will focus on considering acquisition targets primarily in Europe and Asia](https://longbridge.com/en/news/237955221.md)
*2025-04-29T01:55:50.000Z*
> Huaxia Eye stated during an institutional research that according to the latest strategic layout, the company has also b

### [Huaxia Eye: Changes in tariffs will not adversely affect the company's normal operations](https://longbridge.com/en/news/236981910.md)
*2025-04-22T12:57:40.000Z*
> On April 22nd, Huaxia Eye stated on the interactive platform that the company has established long-term stable cooperati